PFE vs STRO
Pfizer Inc (PFE) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported PFE revenue for 2025-12-31 was $62.58B. Net income was $7.77B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
PFE currently screens at market cap $147.73B and trailing P/E 19.8. STRO currently screens at market cap $470.8M.
Not investment advice. Open the PFE and STRO stock pages for the full models.
Not investment advice.